Research Article
Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
Table 1
Patient information.
| | Count (%) |
| Age, y, median (range) | 74 (35–94) | Sex | | Male | 63 (78) | Female | 18 (22) | Type | | Pleural | 80 (99) | Peritoneal | 1 (1) | Subtype | | Epithelioid | 57 (70) | Biphasic | 13 (16) | Sarcomatoid | 11 (14) | Treatment | | Surgery | 2 (2) | Chemotherapy | 23 (28) | Radiotherapy | 9 (11) | BAP1 score (surgical) | | <50% | 47 (58) | ≥50% | 34 (42) | BAP1 score (cytology) | | <50% | 34 (60) | ≥50% | 23 (40) |
|
|
Extrapleural pneumonectomy: EPP.
|